The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis
出版年份 2018 全文链接
标题
The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-05-31
DOI
10.1038/s41598-018-26811-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer
- (2017) Kensaku Yoshida et al. Oncotarget
- FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
- (2016) Muralidharan K Chllamma et al. BRITISH JOURNAL OF CANCER
- Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
- (2016) Stacey M Stein et al. BRITISH JOURNAL OF CANCER
- First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors
- (2016) Caterina Vivaldi et al. INTERNATIONAL JOURNAL OF CANCER
- FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
- (2016) SJ Rombouts et al. Journal of Cancer
- Investigation of the tolerability of FOLFIRINOX in patients with unresectable advanced pancreatic cancer: Single-institution experience in Japan.
- (2015) Kouichirou Miyashita et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability
- (2015) Ronica H. Nanda et al. JOURNAL OF SURGICAL ONCOLOGY
- Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
- (2014) Marlo Blazer et al. ANNALS OF SURGICAL ONCOLOGY
- Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
- (2014) Gillian K Gresham et al. BMC CANCER
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- A Bayesian Meta-Analysis of Multiple Treatment Comparisons of Systemic Regimens for Advanced Pancreatic Cancer
- (2014) Kelvin Chan et al. PLoS One
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- Treatment options for advanced pancreatic cancer: a review
- (2012) Rahma Warsame et al. Expert Review of Anticancer Therapy
- PRM1 Kaplan-Meier Survival Curves: A Potential Source of Data for Systematic Reviews
- (2012) J. Gupta et al. VALUE IN HEALTH
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advanced pancreatic carcinoma: current treatment and future challenges
- (2010) Anastasios Stathis et al. Nature Reviews Clinical Oncology
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of mortality rates for pancreatic cancer across the world
- (2008) D. Hariharan et al. HPB
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now